Termination of License Agreement Sample Contracts
XOMA IRELAND LIMITED Shannon Airport House Shannon, County Clare IrelandTermination of License Agreement • August 13th, 2003 • Xoma LTD /De/ • Pharmaceutical preparations
Reference is made to that certain License Agreement dated as of January 25, 2000 (the "License Agreement") between XOMA Ireland Limited, a company with limited liability organized under the laws of the Republic of Ireland ("XOMA"), and Baxter Healthcare Corporation, a Delaware corporation ("Baxter"). Capitalized terms used and not defined herein shall have the meanings ascribed to them in the License Agreement.
TERMINATION OF LICENSE AGREEMENTTermination of License Agreement • November 13th, 2024 • Wyoming
This Termination of License Agreement (the "Agreement") is entered into on this day of , 2024 (the "Effective Date"), by and between the CITY OF LANDER, a municipal corporation, of 240 Lincoln Street, Lander, Wyoming 82520, herein referred to as “OWNER or OWNERS”, and the K & L INVESTMENTS, LLC, a Wyoming Limited Liability Company whose principal office is 3907 E. 19th Street, Casper, Wyoming, herein referred to as “LICENSEE”. Owner and Licensee may be referred to herein individually as a “Party” or collectively as the “Parties.”
TERMINATION OF LICENSE AGREEMENT AB INITIOTermination of License Agreement • September 18th, 2017 • Level Brands, Inc. • Perfumes, cosmetics & other toilet preparations • North Carolina
This TERMINATION OF LICENSE AGREEMENT AB INITIO (this “Agreement”) is by and between I|M 1, LLC, a California limited liability company (the "Licensor") and NuGene International, Inc., a Nevada corporation (the "Licensee").
AGREEMENT FOR TERMINATION OF LICENSE AGREEMENTTermination of License Agreement • October 13th, 2015 • Peak Pharmaceuticals, Inc. • Pharmaceutical preparations • Colorado
THIS AGREEMENT FOR TERMINATION OF LICENSE AGREEMENT, is made and entered into this 12th day of October, 2015, to be effective as of October 1, 2015, by and between CANNA-PET, LLC, a Washington limited liability company (‘LICENSOR”), and PEAK BIOPHARMA CORP., a Colorado corporation (‘LICENSEE’).
TERMINATION OF LICENSE AGREEMENTTermination of License Agreement • March 7th, 2024 • Fresh Tracks Therapeutics, Inc. • Biological products, (no disgnostic substances)
This Termination of License Agreement (this “Agreement”) is made and entered into as of March 1, 2024 by and between Carna Biosciences, Inc., a corporation organized under the laws of Japan (“Carna”) and Fresh Tracks Therapeutics, Inc. (f/k/a Brickell Biotech, Inc.), a Delaware corporation (“FRTX”).